Basic info
Industry
biotechnology research
Sectors
Biotechnology
Disease Models
Organ Transplant
Cancer metastasis
Regenerative medicine
Preclinical Models
Regenerative Medicine
Drug screening
Biomaterials
2D ECM coating
Cancer research
Fibrosis Research
2D cell culture
Cancer Research
Extracellular matrix
Tissue Engineering
in vitro research tools
Extracellular Matrix
NASH
Stem cell research
Services
Health Care
Fibrosis
3D cell culture
ECM scaffolds
Drug Development
IPF
Compound testing
Life Science
Date founded
2016
Funding rounds raised
Total raised
$225K
from 2 investors over 2 rounds
X
Xylyx Bio, Inc. raised $225K on October 22, 2018
Investors: National Heart, Lung, and Blood Institute
X
Xylyx Bio, Inc. raised undisclosed on December 1, 2016
Investors: Boston Harbor Angels Inc.